Stonepine Capital Management, LLC ACAD Holdings History
Stonepine Capital Management, LLC's ACADIA Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Stonepine Capital Management, LLC held 93,393.00 shares of ACADIA Pharmaceuticals Inc(ACAD), totaling $185,850.00. This investment constitutes 0.18% of their stock portfolio, and Stonepine Capital Management, LLC now holds 0.06% of the outstanding ACADIA Pharmaceuticals Inc(ACAD) stock.
The initial trade took place in 2018Q2. And since then Stonepine Capital Management, LLC has made 4 purchases of ACAD, at an average price of $17.18, for a total of 414,900.00 shares. In addition, there have been 2 sales at an average price of $16.68 for 321,507.00 shares. Based on historical transaction data and ACAD's current price of $22.12, Stonepine Capital Management, LLC's estimated gain on his ACAD holdings is $300,409.00, reflecting a 4.21% gain to date.
Stonepine Capital Management, LLC ACAD ($22.12) Holding Chart
Stonepine Capital Management, LLC ACAD ($22.12) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1